Carlsbad, CA, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, today announced the closing of its previously announced underwritten public offering for gross proceeds of approximately $5 million prior to deducting underwriting commissions and offering expenses. The offering is comprised of (i) 158,000 Class A Units with each unit consisting of (a) one share of common stock and (b) one common warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 3,120,688 Class B Units with each unit consisting of (a) one prefunded common stock purchase warrant to purchase one share of common stock (“Prefunded Warrants”) and (b) one Common Warrant. The price per Class A Unit is $1.525 and the price per Class B Unit is $1.5249 (collectively, the “Offering”). The Common Warrants have an exercise price of $1.40 per share, are exercisable at issuance, and have a term expiring five years from issuance. Ladenburg Thalmann & Co. Inc. acted as sole bookrunning manager in connection with this Offering. In addition, the Company has granted the underwriter a 45-day option to purchase up to 491,803 additional shares of common stock and/or Common Warrants, solely to cover over-allotments, if any, at the public offering price less the underwriting discounts and commissions. In connection with the Offering, the Company has elected to reprice approximately one million previously issued warrants to $1.40 per share. The gross proceeds from the Offering to the Company, before deducting underwriting discounts and commissions and other Offering expenses and excluding any proceeds that may be received upon the exercise of the Common Warrants and the exercise of the underwriter’s option to purchase additional shares of common stock and/or Common Warrants, were approximately $5 million. The Company currently intends to use the net proceeds of the Offering primarily to fund our Phase 1 clinical trial of PALI-2108, pre-clinical studies, research and development, and working capital. The securities were offered pursuant to a registration statement on Form S-1 (File No. 333-282883), which was declared effective by the United States Securities and Exchange Commission (“SEC”) on December 12, 2024. The securities may be offered only by means of a prospectus which forms part of the effective registration statement. A preliminary prospectus describing the terms of the Offering has been filed with the SEC and is available on the SEC’s website located at http://www.sec.gov . A final prospectus relating to this Offering was filed by the Company with the SEC. Electronic copies of the final prospectus relating to the Offering, when available, may also be obtained by contacting Ladenburg Thalmann & Co. Inc., Prospectus Department, 640 Fifth Avenue, 4th Floor, New York, New York 10019 or by email at prospectus@ladenburg.com . This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. About Palisade Bio Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com . Forward Looking Statements This communication contains “forward-looking” statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the over-allotment option. These forward-looking statements are based on the Company’s current expectations. Forward-looking statements involve risks and uncertainties. The Company’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the intended use of net proceeds from the Offering, the extent of our cash runway; our ability to successfully develop our licensed technologies; the timing and outcome of our current and anticipated applications and studies related to our product candidates; estimates about the size and growth potential of the markets for our product candidates, and our ability to serve those markets, including any potential revenue generated; future regulatory, judicial, and legislative changes or developments in the United States (U.S.) and foreign countries and the impact of these changes; our ability to maintain the Nasdaq listing of our securities; our ability to build a commercial infrastructure in the U.S. and other markets; our ability to compete effectively in a competitive industry; our ability to identify and qualify manufacturers to provide API and manufacture drug product; our ability to enter into commercial supply agreements; the success of competing technologies that are or may become available; our ability to attract and retain key scientific or management personnel; the accuracy of our estimates regarding expenses, future revenues, capital requirements and needs for additional financing; our ability to obtain funding for our operations; our ability to attract collaborators and strategic partnerships; and the impact of any global event on our business, and operations, and supply. Any statements contained in this communication that are not statements of historical fact may be deemed to be forward-looking statements. These forward-looking statements are based upon the Company’s current expectations. Forward-looking statements involve risks and uncertainties. The Company’s actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the Company’s ability to advance its nonclinical and clinical programs, the uncertain and time-consuming regulatory approval process; and the Company’s ability to secure additional financing to fund future operations and development of its product candidates. Additional risks and uncertainties can be found in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 26, 2024, and the Quarterly Reports on Form 10-Q or other SEC filings that are filed thereafter, including the Registration Statement on Form S-1. These forward-looking statements speak only as of the date hereof, and the Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. Investor Relations Contact JTC Team, LLC Jenene Thomas 908-824-0775 PALI@jtcir.comVikings QB Sam Darnold is a bona fide MVP candidate and should be taken seriously'Is This A Joke?': Don Lemon Slams Time For Making Trump 'Person Of The Year'
Smart Shower Systems Market Expands as Demand for Home Automation Solutions IncreasesNoneCLINTON, S.C. (AP) — Quante Jennings rushed for 190 yards and a tiebreaking touchdown as Presbyterian beat Butler 30-20 in a regular-season finale on Saturday. Collin Hurst threw for 172 yards and two scores and ran for another for the Blue Hose (6-6, 4-4 Pioneer League). Reagan Andrew threw for three touchdowns and was intercepted once for the Bulldogs (9-3, 5-3). Jennings' 50-yard rush led to Hurst's 17-yard touchdown pass to Worth Warner to tie the game at 20 midway through the third quarter. Presbyterian's next possession began on the Butler 30 after a short punt from deep in Bulldogs territory, and five plays later Jennings scored from 10 yards out. Peter Lipscombe made it a 10-point lead with a field goal with 2:15 to go after a 15-play, 89-yard drive that took over 10 minutes. About a minute later, Andrew threw a 42-yard score to Ethan Loss but the Blue Hose recovered the onside kick. The Blue Hose defeated a ranked FCS team — Butler (9-3, 5-3) is No. 23 in the coaches poll — for the first time in its Division I history that began in 2007. ___ AP college football: and . Sign up for the AP’s college football newsletter: The Associated Press
Xbox has added nearly 400 titles that aren’t available with Game Pass to its app. “Earlier this [Northern] summer, we began working with partners to bring all PC games with Xbox features into the Xbox app,” said Chris Charla, GM of Content Curation and Programs at Xbox. “We’re super excited to see what Xbox games come to Windows PC from game creators in the future and to welcome nearly 400 titles that previously weren’t discoverable or purchasable in the Xbox app.” Members of the Xbox Insiders Program have had access to the new Xbox Home “experience” since late October, and it’s now available in the Xbox app on Windows PC for all players. Among the titles in the app are dozens of games from Japanese studios Kemco and Kairosoft, and games collections such as Shovel Knight: Treasure Trove and The Jackbox Party Pack. More than 100 of the newly added titles are Xbox Play Anywhere, meaning if players buy the Xbox console version, they can play the Xbox PC version as well (and vice versa). The new Home “highlights featured content so players can stay up to date on game releases, new events, Game Pass content, sales, and more”. Xbox said there are new curated collections and recommendations, deals and discounts, and the Jump back in feature, which enables players in Compact Mode to click on any game card and jump back into gameplay from the game’s hub. Charla said that with growth in the Windows handheld gaming category, the app is “a great way for developers to meet current and future players where they are, so they have the freedom and ability to play the games they want, with the friends they want, anywhere they want”. He said in coming months Xbox would be piloting and testing new features. In December a small collection of casual games including Candy Crush Soda Saga and Angry Birds 2 will be tested in the Xbox app.
Lithium Argentina Files Meeting Materials to Establish Corporate Domicile in Switzerland
None
WASHINGTON (AP) — As a former and potentially future president, Donald Trump hailed what would become Project 2025 as a road map for “exactly what our movement will do” with another crack at the White House. As the blueprint for a hard-right turn in America became a liability during the 2024 campaign, Trump pulled an about-face . He denied knowing anything about the “ridiculous and abysmal” plans written in part by his first-term aides and allies. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get the latest news, sports, weather and more delivered right to your inbox.
Nokia Corporation Stock Exchange Release 13 December 2024 at 22:30 EET Nokia Corporation: Repurchase of own shares on 13.12.2024 Espoo, Finland – On 13 December 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: * Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 3 April 2024 started on 25 November 2024 and end by 31 December 2025 and target to repurchase 150 million shares for a maximum aggregate purchase price of EUR 900 million. Total cost of transactions executed on 13 December 2024 was EUR 3,680,494. After the disclosed transactions, Nokia Corporation holds 214,265,592 treasury shares. Details of transactions are included as an appendix to this announcement. On behalf of Nokia Corporation BofA Securities Europe SA About Nokia At Nokia, we create technology that helps the world act together. As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs. With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future. Inquiries: Nokia Communications Phone: +358 10 448 4900 Email: press.services@nokia.com Maria Vaismaa, Global Head of External Communications Nokia Investor Relations Phone: +358 40 803 4080 Email: investor.relations@nokia.com Attachment Daily Report 2024-12-13Hunter, Jeanty give Heisman ceremony a different vibe
I'm a Celeb fans slam 'aggressive' Dean McCullough in argument with Alan Halsall
After Trump's Project 2025 denials, he is tapping its authors and influencers for key rolesChuck Woolery, smooth-talking game show host of ‘Love Connection' and ‘Scrabble,' dies at 83Jennings rushes for tiebreaking touchdown and Presbyterian defeats Butler 30-27
EU, U.S pledge to boost COP29 climate finance offer
With two-way star Travis Hunter of Colorado and Boise State running back Ashton Jeanty leading the field, these certainly aren't your typical Heisman Trophy contenders. Sure, veteran quarterbacks Dillon Gabriel from top-ranked Oregon and Cam Ward of No. 15 Miami are finalists for college football's most prestigious award as well, but the 90th annual ceremony coming up Saturday night at Lincoln Center in New York City offers a fresh flavor this year. To start with, none of the four are from the powerhouse Southeastern Conference, which has produced four of the past five Heisman winners — two each from Alabama and LSU. Jeanty, who played his home games for a Group of Five team on that peculiar blue turf in Idaho more than 2,100 miles from Manhattan, is the first running back even invited to the Heisman party since 2017. After leading the country with 2,497 yards rushing and 29 touchdowns, he joined quarterback Kellen Moore (2010) as the only Boise State players to be named a finalist. "The running back position has been overlooked for a while now," said Jeanty, who plans to enter the 2025 NFL draft. "There's been a lot of great running backs before me that should have been here in New York, so to kind of carry on the legacy of the running back position I think is great. ... I feel as if I'm representing the whole position." With the votes already in, all four finalists spent Friday conducting interviews and sightseeing in the Big Apple. They were given custom, commemorative watches to mark their achievement. "I'm not a watch guy, but I like it," said Hunter, flashing a smile. The players also took photos beneath the massive billboards in Times Square and later posed with the famous Heisman Trophy, handed out since 1935 to the nation's most outstanding performer. Hunter, the heavy favorite, made sure not to touch it yet. A dominant player on both offense and defense who rarely comes off the field, the wide receiver/cornerback is a throwback to generations gone by and the first full-time, true two-way star in decades. On offense, he had 92 catches for 1,152 yards and 14 touchdowns this season to help the 20th-ranked Buffaloes (9-3) earn their first bowl bid in four years. On defense, he made four interceptions, broke up 11 passes and forced a critical fumble that secured an overtime victory against Baylor. Hunter played 688 defensive snaps and 672 more on offense — the only Power Four conference player with 30-plus snaps on both sides of the ball, according to Colorado research. Call him college football's answer to baseball unicorn Shohei Ohtani. "I think I laid the ground for more people to come in and go two ways," Hunter said. "It starts with your mindset. If you believe you can do it, then you'll be able to do it. And also, I do a lot of treatment. I keep up with my body. I get a lot of recovery." Hunter is Colorado's first Heisman finalist in 30 years. The junior from Suwanee, Georgia, followed flashy coach Deion Sanders from Jackson State, an HBCU that plays in the lower level FCS, to the Rocky Mountains and has already racked up a staggering combination of accolades this week, including The Associated Press player of the year. Hunter also won the Walter Camp Award as national player of the year, along with the Chuck Bednarik Award as the top defensive player and the Biletnikoff Award for best wide receiver. "It just goes to show that I did what I had to do," Hunter said. Next, he'd like to polish off his impressive hardware collection by becoming the second Heisman Trophy recipient in Buffaloes history, after late running back Rashaan Salaam in 1994. "I worked so hard for this moment, so securing the Heisman definitely would set my legacy in college football," Hunter said. "Being here now is like a dream come true." Jeanty carried No. 8 Boise State (12-1) to a Mountain West Conference championship that landed the Broncos the third seed in this year's College Football Playoff. They have a first-round bye before facing the SMU-Penn State winner in the Fiesta Bowl quarterfinal on New Year's Eve. The 5-foot-9, 215-pound junior from Jacksonville, Florida, won the Maxwell Award as college football's top player and the Doak Walker Award for best running back. Jeanty has five touchdown runs of at least 70 yards and has rushed for the fourth-most yards in a season in FBS history — topping the total of 115 teams this year. He needs 132 yards to break the FBS record set by Heisman Trophy winner Barry Sanders at Oklahoma State in 1988. In a pass-happy era, however, Jeanty is trying to become the first running back to win the Heisman Trophy since Derrick Henry for Alabama nine years ago. In fact, quarterbacks have snagged the prize all but four times this century. Gabriel, an Oklahoma transfer, led Oregon (13-0) to a Big Ten title in its first season in the league and the No. 1 seed in the College Football Playoff. The steady senior from Hawaii passed for 3,558 yards and 28 touchdowns with six interceptions. His 73.2% completion rate ranks second in the nation, and he's attempting to join quarterback Marcus Mariota (2014) as Ducks players to win the Heisman Trophy. "I think all the memories start to roll back in your mind," Gabriel said. Ward threw for 4,123 yards and led the nation with a school-record 36 touchdown passes for the high-scoring Hurricanes (10-2) after transferring from Washington State. The senior from West Columbia, Texas, won the Davey O'Brien National Quarterback of the Year award and is looking to join QBs Vinny Testaverde (1986) and Gino Torretta (1992) as Miami players to go home with the Heisman. "I just think there's a recklessness that you have to play with at the quarterback position," Ward said.Adobe weaker revenue guidance for current quarter offsets Q4 results beat
Gov. Wes Moore, Mayor Brandon Scott announce planned festival to reinvigorate money-losing PreaknessHow Nurse’s return to a simple game has elevated his playNever Let The Truth Get In the Way of a Good Story: CBS News Plays Dangerous Character Assassination Game